Growth Metrics

SOPHiA GENETICS (SOPH) Share-based Compensation (2020 - 2025)

SOPHiA GENETICS's Share-based Compensation history spans 6 years, with the latest figure at $3.9 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation fell 23.83% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.2 million, a 1.72% decrease, with the full-year FY2025 number at $16.2 million, down 1.72% from a year prior.
  • Share-based Compensation hit $3.9 million in Q4 2025 for SOPHiA GENETICS, down from $4.1 million in the prior quarter.
  • Over the last five years, Share-based Compensation for SOPH hit a ceiling of $5.1 million in Q4 2024 and a floor of $639000.0 in Q1 2021.
  • Historically, Share-based Compensation has averaged $3.5 million across 5 years, with a median of $3.8 million in 2024.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 897.26% in 2021 and later decreased 29.99% in 2023.
  • Tracing SOPH's Share-based Compensation over 5 years: stood at $3.6 million in 2021, then fell by 28.68% to $2.6 million in 2022, then surged by 62.21% to $4.2 million in 2023, then rose by 20.59% to $5.1 million in 2024, then fell by 23.83% to $3.9 million in 2025.
  • Business Quant data shows Share-based Compensation for SOPH at $3.9 million in Q4 2025, $4.1 million in Q3 2025, and $4.4 million in Q2 2025.